AND COST-EFFECTIVENESS ANALYSIS OF ADVERSE ATRIAL FIBRILLATION OUTCOME IN TREATING OSTEOPROSIS

被引：2
|
作者：
Kao, Y. H. [1 ]
Chang, L. C. [1 ]
Tsai, Y. W. [1 ]
Chen, L. K. [2 ]
Huang, W. F. [1 ]
机构：
[1] Natl Yang Ming Univ, Taipei 112, Taiwan
[2] Taipei Vet Gen Hosp, Taipei, Taiwan
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1102
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A217 / A217
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF APIXABAN IN THE TREATMENT OF ATRIAL FIBRILLATION IN MEXICO
    Galindo-Suarez, R. M.
    Davila-Veites, A.
    Olguin-Sanchez, J. F.
    Haddad, A.
    del Angel-Martinez, J.
    Mucino-Ortega, E.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A524 - A524
  • [2] A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation
    Gisèle Nakhlé
    Jean-Claude Tardif
    Denis Roy
    Léna Rivard
    Michelle Samuel
    Anick Dubois
    Jacques LeLorier
    [J]. Molecular Diagnosis & Therapy, 2023, 27 : 383 - 394
  • [3] A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation
    Nakhle, Gisele
    Tardif, Jean-Claude
    Roy, Denis
    Rivard, Lena
    Samuel, Michelle
    Dubois, Anick
    LeLorier, Jacques
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (03) : 383 - 394
  • [4] Cost-effectiveness of catheter ablation for atrial fibrillation
    Khaykin, Yaariv
    [J]. CURRENT OPINION IN CARDIOLOGY, 2007, 22 (01) : 11 - 17
  • [5] Cost-effectiveness of atrial fibrillation catheter ablation
    Andrikopoulos, George
    Tzeis, Stylianos
    Maniadakis, Nikos
    Mavrakis, Hercules E.
    Vardas, Panos E.
    [J]. EUROPACE, 2009, 11 (02): : 147 - 151
  • [6] THE USE OF THE PROPENSITY SCORE IN THE COST-EFFECTIVENESS ANALYSIS OF THE ATRIAL FIBRILLATION TREATMENT
    Kamensky, V
    Bulkova, V
    Bohacova, J.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A615 - A616
  • [7] Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis
    Welton, Nicky J.
    McAleenan, Alexandra
    Thom, Howard H. Z.
    Davies, Philippa
    Hollingworth, Will
    Higgins, Julian P. T.
    Okoli, George
    Sterne, Jonathan A. C.
    Feder, Gene
    Eaton, Diane
    Hingorani, Aroon
    Fawsitt, Christopher
    Lobban, Trudie
    Bryden, Peter
    Richards, Alison
    Sofat, Reecha
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (29) : 1 - +
  • [8] COST-EFFECTIVENESS ANALYSIS OF ATRIAL FIBRILLATION SCREENING IN THE ELDERLY POPULATION OF TAIWAN
    Fu, Y. H.
    Chao, T. F.
    Yeh, Y. H.
    Chan, Y. H.
    Chien, H. T.
    Lin, F. J.
    Chen, S. A.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S130 - S130
  • [9] Use of mHealth Devices to Screen for Atrial Fibrillation: Cost-Effectiveness Analysis
    Giebel, Godwin D.
    [J]. JMIR MHEALTH AND UHEALTH, 2020, 8 (10):
  • [10] Cost-effectiveness analysis of ximelagatran for the prevention of stroke in atrial fibrillation.
    O'Brien, C
    Gage, B
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 : 133 - 133
12345